Breast Drug Notifications

Discussion in 'Seattle Genetics' started by anonymous, Dec 20, 2019 at 6:02 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    I got notified from Bowdoin group that I am not moving forward. Anyone else? Clearly they are not interested in many of the Genentech people based on what the recruiter said. Good luck to everyone else.
     

  2. anonymous

    anonymous Guest

    Funny... Just wait...
     
  3. anonymous

    anonymous Guest

    Yes only interested in the Genentech reps who have breast experience. Anything other then breast c ya!
     
  4. anonymous

    anonymous Guest

    Not even that interested in reps with breast from Genentech. Was told by the new RSD that they are limited in# of Genentech people they can hire.
     
  5. anonymous

    anonymous Guest

    Just wait..
     
  6. anonymous

    anonymous Guest

    Don't have to. You will see some but many will be surprised.
     
  7. anonymous

    anonymous Guest

    SG, congratulations on a new niche in Breast Cancer world.
    You will have some great people come over from Genentech. What does it matter if they are all from
    there? If they are qualified and make a good fit for the team, what difference would it make? These statements of too many from one company almost sounds like discrimination. I thought we were about quality not quantity. Good luck happy some were able to land a job at SG. Merry Christmas!
     
  8. anonymous

    anonymous Guest

    Simple. Controlling the # that come over so that we don't foster the same culture as Genentech. Good company but different than here.
     
  9. anonymous

    anonymous Guest

    Please. This is pharma/Biopharma whatever. You are very fortunate to sell/manage great drugs with incredible margins. The sales business could be run effectively by candidates with HS diplomas.

    I'm sure many of the new managers will be very busy doing this job and getting great benefits/compensation while running other companies.

    Good selling.
     
  10. anonymous

    anonymous Guest

    Breast experience from Genentech = no experience in a competitive sale and no selling a pill. Hopefully those with oral oncolytic experience have a hands up in this process because SG has no clue in this marketplace.
     
  11. anonymous

    anonymous Guest

    Good luck to all, stop being a "Debby Downer". Xeloda was a pill you idiot.
     
  12. anonymous

    anonymous Guest

    And Xeloda was quite the therapeutic breakthrough. Hey doctor 5FU now comes in a pill form!
     
  13. anonymous

    anonymous Guest

    You are still an idiot. Get a career! LOL
     
  14. anonymous

    anonymous Guest

    This is going to be a clown show. With approval you are looking at a triplicate combination. Puma and Daichi will make heyday of this compound. We all need another TKI (Multiple on market) The Genenetech clones will destroy this company. Herceptin was an easy sell many years ago. Why do you think Genentech has a clue. We ill fail due to the hiring of idiots at top. Beware of Genentech non working yes men.
     
  15. anonymous

    anonymous Guest

    Have you seen what is happening at Genentech? Why would you want that? The people that are left are the people that caused it. Do not hire these left overs.